Medpace Holdings (MEDP) Tax Provisions (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Tax Provisions came in at $30.3 million in Q2 2026, down 11.6% on a YoY basis from $34.3 million in Q2 2025, and up 27.74% quarter-over-quarter from $23.7 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Tax Provisions (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Tax Provisions for 12 consecutive years, with $30.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Provisions fell 11.6% year-over-year to $30.3 million; the trailing twelve-month figure through Jun 2026 stood at $107.4 million (up 39.39% YoY), and the FY2025 full-year result was $91.3 million, up 27.56% from the prior year.
- Tax Provisions improved to $30.3 million in Q2 2026 per MEDP's latest filing, from $23.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $34.3 million in Q2 2025 and bottomed at $3.6 million in Q1 2025.
- Historically, Tax Provisions has averaged $17.1 million across 5 years, with a median of $15.3 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Tax Provisions plunged 64.92% in 2025, then jumped 563.52% in 2026.
- Over 5 years, Tax Provisions stood at $5.0 million in 2022, then jumped by 149.43% to $12.4 million in 2023, then soared by 35.9% to $16.9 million in 2024, then gained by 28.68% to $21.7 million in 2025, then surged by 39.64% to $30.3 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $30.3 million, $23.7 million, and $21.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 60.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 30.30 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -19.62 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 53.93 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 12.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 128,000.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 11,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -113.32 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.30 Mn |
| Mar 31, 2026 | 23.72 Mn |
| Dec 31, 2025 | 21.70 Mn |
| Sep 30, 2025 | 31.70 Mn |
| Jun 30, 2025 | 34.28 Mn |
| Mar 31, 2025 | 3.58 Mn |
| Dec 31, 2024 | 16.86 Mn |
| Sep 30, 2024 | 22.35 Mn |
| Jun 30, 2024 | 22.13 Mn |
| Mar 31, 2024 | 10.19 Mn |
| Dec 31, 2023 | 12.41 Mn |
| Sep 30, 2023 | 12.65 Mn |
| Jun 30, 2023 | 14.68 Mn |
| Mar 31, 2023 | 13.14 Mn |
| Dec 31, 2022 | 4.98 Mn |
| Sep 30, 2022 | 15.87 Mn |
| Jun 30, 2022 | 12.64 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 5.89 Mn |
| Sep 30, 2021 | 6.16 Mn |